Citigroup Inc. (NYSE:C)’s CFO Gonzalo Luchetti said the bank expects return on tangible common equity (RoTCE) to come in slightly above 11% in 2026, while also indicating that Citi will increase stock buybacks from the $13 billion repurchased in 2025. The bank plans to accelerate roughly $500 million of investment by year-end, including spending on severance and marketing intended to expand its credit-card and wealth-management businesses. Citi also expects to remove Banamex from its balance sheet in 2027, which will create an estimated $9 billion currency-translation adjustment loss.
The 11%+ target is meaningful because Citi’s profitability has already improved materially. In the second quarter, Citi generated $24.8 billion of revenue, up 14% year over year, while net income rose 45% to $5.8 billion. Investment-banking revenue increased 44% to $1.55 billion, and net interest income increased 13%. Citi’s SEC filing shows second-quarter RoTCE of 13.0%, versus 8.7% a year earlier, while the first half of 2026 produced a 13.1% RoTCE. The new guidance therefore suggests management believes profitability can remain above the longer-term 11%-13% RoTCE range Citi established for 2027-28, despite additional investment spending.
Kiev.Victor / Shutterstock.com
Stronger Businesses and Buybacks Could Lift Citi’s Returns Further
The bullish argument is that Citigroup Inc. appears to be converting its multiyear restructuring into higher returns while simultaneously returning more capital to shareholders. The move from 8.7% RoTCE in the second quarter of 2025 to 13.0% in the second quarter of 2026 represents a substantial improvement in capital efficiency. Citi’s efficiency ratio also improved to 57.4% from 62.7%, indicating that revenue growth is increasingly translating into operating leverage rather than being absorbed by expenses. That is particularly relevant because management now intends to spend another roughly $500 million on severance, marketing, and growth initiatives; if these investments produce the intended expansion in cards and wealth management, they could support revenue growth without derailing the profitability trajectory.
Capital returns provide another positive lever. Citi repurchased $13 billion of stock in 2025 and now expects to increase that amount, while its June 2026 CET1 ratio remained 12.78%, comfortably above its 11.6% standardized regulatory requirement. Buybacks can reduce tangible common equity and shares outstanding, potentially supporting both RoTCE and per-share earnings when executed below intrinsic value. Citi’s tangible book value per share had already risen 7% year over year to $100.89 by June 30, 2026. The combination of higher operating profitability, shrinking share count, and improving capital efficiency strengthens the case for a valuation re-rating if Citi can sustain returns above 11%.
The broader revenue environment also remains supportive for Citigroup Inc.’s markets, investment banking, and wealth-management franchises. Second-quarter investment-banking revenue jumped 44%, while wealth-management revenue grew 13%, showing that Citi’s targeted businesses are gaining momentum. A potentially higher-rate environment could also support certain banking revenue streams, although the benefits would depend on deposit pricing and credit performance. Reuters reported that markets were expecting another Federal Reserve rate increase amid persistent inflation, while the 10-year Treasury yield moved above 5%, creating a higher-rate backdrop for banks.
Rising Costs Could Challenge Citi’s Profitability Gains
The main risk is that Citigroup Inc.’s improved returns may prove more dependent on unusually strong market activity and investment-banking conditions than the 11% target implies. Second-quarter results benefited from a 44% increase in investment-banking revenue and strong trading activity, but the environment is becoming less predictable. Bank of America, for example, expects its third-quarter investment-banking fees to fall at least 10%, while sales and trading revenue is expected to be flat. If industrywide deal activity or trading revenue weakens, Citi could struggle to maintain the elevated revenue base that helped produce its 13% second-quarter RoTCE.
Expense execution is an additional concern. Citi’s second-quarter operating expenses increased 5% to $14.2 billion, with higher compensation, product-servicing costs and deposit-insurance expenses. Management is now accelerating another $500 million of investment even as investors had previously reacted negatively to concerns about rising expenses. Reuters reported that Citi shares fell 4.2% after its second-quarter results despite the earnings beat, with investors focused on expenses and the bank’s cautious profitability outlook. If the new spending produces revenue only gradually, near-term operating leverage could deteriorate and leave the 11% RoTCE target more exposed to weaker markets or credit conditions.
Capital deployment also has limits. Citigroup Inc.’s CET1 ratio fell from year-end 2025 largely because of share repurchases, dividends, and higher risk-weighted assets, even though net income and asset sales provided offsets. At the same time, credit RWAs increased because of higher derivatives and securities-financing activity, corporate-lending growth, and the acquisition of an additional American Airlines co-branded card portfolio. This means accelerating buybacks while expanding the balance sheet requires careful capital management. The planned 2027 removal of Banamex adds another complication, with management expecting a $9 billion currency-translation adjustment loss. Although that loss is not necessarily indicative of recurring operating profitability, it could create a substantial accounting drag and complicate comparisons of reported equity and returns.
Conclusion
Citigroup Inc.’s 11%+ RoTCE target strengthens the bullish case as restructuring, stronger revenue and buybacks improve capital efficiency. However, elevated investment spending and reliance on strong capital-markets activity create execution risks. Overall, Citi’s outlook is positive if it can sustain higher returns beyond the current favorable market environment.
READ NEXT: Lilly’s Foundayo Quickly Gains Ground in the Oral Weight-Loss Market and Abbott Faces $384 Million Cost as Infant Formula Legal Risks Persist
This article is originally published at Insider Monkey.
